[1]
|
Camici, P.G., D’Amati, G. and Rimoldi, O. (2015) Coronary Microvascular Dysfunction: Mechanisms and Functional Assessment. Nature Reviews Cardiology, 12, 48-62. https://doi.org/10.1038/nrcardio.2014.160
|
[2]
|
Lanza, G.A. and Crea, F. (2010) Primary Coronary Microvascular Dysfunction: Clinical Presentation, Pathophysiology, and Management. Circulation, 121, 2317-2325. https://doi.org/10.1161/CIRCULATIONAHA.109.900191
|
[3]
|
Crea, F., Lanza, G.A. and Camici, P.G. (2014) Coronary Microvascular Dysfunction. Springer Verlag, Berlin.
https://doi.org/10.1007/978-88-470-5367-0
|
[4]
|
Camici, P.G., Olivotto, I. and Rimoldi, O.E. (2012) The Coronary Circulation and Blood Flow in Left Ventricular Hypertrophy. Journal of Molecular and Cellular Cardiology, 52, 857-864. https://doi.org/10.1016/j.yjmcc.2011.08.028
|
[5]
|
Camici, P.G. and Crea, F. (2007) Coronary Microvascular Dysfunction. The New England Journal of Medicine, 356, 830-840. https://doi.org/10.1056/NEJMra061889
|
[6]
|
Kaufmann, P.A., Gnecchi-Ruscone, T., Di Terlizzi, M., Schafers, K.P., Luscher, T.F. and Camici, P.G. (2000) Coronary Heart Disease in Smokers: Vitamin C Restores Coronary Microcirculatory Function. Circulation, 102, 1233-1238.
https://doi.org/10.1161/01.CIR.102.11.1233
|
[7]
|
Lanza, G.A. and Crea, F. (2010) Primary Coronary Microvascular Dysfunction: Clinical Presentation, Pathophysiology, and Management. Circulation, 121, 2317-2325. https://doi.org/10.1161/CIRCULATIONAHA.109.900191
|
[8]
|
Anand, S.S., et al. (2008) Risk Factors for Myocardial Infarction in Women and Men: Insights from the Interheart Study. European Heart Journal, 29, 932-940. https://doi.org/10.1093/eurheartj/ehn018
|
[9]
|
Rimm, E.B. and Willett, W.C. (2008) Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle. The New England Journal of Medicine, 343, 16-22. https://doi.org/10.1056/NEJM200007063430103
|
[10]
|
Lim, T.K., Choy, A.J., Khan, F., Belch, J.J., Struthers, A.D. and Lang, C.C. (2009) Therapeutic Development in Cardiac Syndrome X: A Need to Target the Underlying Pathophysiology. Cardiovascular Therapeutics, 27, 49-58.
https://doi.org/10.1111/j.1755-5922.2008.00070.x
|
[11]
|
Lanza, G.A., Parrinello, R. and Figliozzi, S. (2014) Management of Microvascular Anginapectoris. American Journal of Cardiovascular Drugs, 14, 31-40. https://doi.org/10.1007/s40256-013-0052-1
|
[12]
|
Treasure, C.B., et al. (1995) Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery Disease. The New England Journal of Medicine, 332, 481-487.
https://doi.org/10.1056/NEJM199502233320801
|
[13]
|
Ridker, P.M., MacFadyen, J., Libby, P. and Glynn, R.J. (1995) Relation of Baseline High-Sensitivity C-Reactive Protein Level to Cardiovascular Outcomes with Rosuvastatin in the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER). American Journal of Cardiology, 106, 204-209.
https://doi.org/10.1016/j.amjcard.2010.03.018
|
[14]
|
Stone, N.J., et al. (2014) 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129, S1-S45.
|
[15]
|
Reriani, M.K., et al. (2011) Effects of Statins on Coronary and Peripheral Endothelial Function in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The European Journal of Cardiovascular Prevention & Rehabilitation, 18, 704-716. https://doi.org/10.1177/1741826711398430
|
[16]
|
Pauly, D.F., et al. (2011) In Women with Symptoms of Cardiac Ischemia, Nonobstructive Coronary Arteries, and Microvascular Dysfunction, Angiotensin-Converting Enzyme Inhibition Is Associated with Improved Microvascular Function: A Double-Blind Randomized Study from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE). American Heart Journal, 162, 678-684. https://doi.org/10.1016/j.ahj.2011.07.011
|
[17]
|
Bavry, A.A., et al. (2014) Aldosterone Inhibition and Coronary Endothelial Function in Women without Obstructive Coronary Artery Disease: An Ancillary Study of the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). American Heart Journal, 167, 826-832. https://doi.org/10.1016/j.ahj.2014.01.017
|
[18]
|
Fraker, T.D., et al. (2017) 2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients with Chronic Stable Angina: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to Develop the Focused Update of the 2002 Guidelines for the Management of Patients with Chronic Stable Angina. Journal of the American College of Cardiology, 50, 2264-2274. https://doi.org/10.1016/j.jacc.2007.08.002
|
[19]
|
Heidenreich, P.A., et al. (1999) Meta-Analysis of Trials Comparing Beta-Blockers, Calcium Antagonists, and Nitrates for Stable Angina. JAMA, 281, 1927-1936. https://doi.org/10.1001/jama.281.20.1927
|
[20]
|
Bugiardini, R., Borghi, A., Biagetti, L. and Puddu, P. (1989) Comparison of Verapamil versus Propranolol Therapy in Syndrome X. American Journal of Cardiology, 63, 286-290. https://doi.org/10.1016/0002-9149(89)90332-9
|
[21]
|
Lanza, G.A., Colonna, G., Pasceri, V. and Maseri, A. (1999) Atenolol versus Amlodipine versus Isosorbide-5-Mononitrate on Anginal Symptoms in Syndrome X. American Journal of Cardiology, 84, 854-856.
https://doi.org/10.1016/S0002-9149(99)00450-6
|
[22]
|
Kayaalti, F., et al. (2010) Effects of Nebivolol Therapy on Endothelial Functions in Cardiac Syndrome X. Heart Vessels, 25, 92-96. https://doi.org/10.1007/s00380-009-1170-1
|
[23]
|
Togni, M., et al. (2007) Does the Beta-Blocker Nebivolol Increase Coronary Flow Reserve? Cardiovascular Drugs and Therapy, 21, 99-108. https://doi.org/10.1007/s10557-006-0494-7
|
[24]
|
Cannon, R.O., Watson, R.M., Rosing, D.R. and Epstein, S.E. (1985) Efficacy of Calcium Channel Blocker Therapy for Angina Pectoris Resulting from Small-Vessel Coronary Artery Disease and Abnormal Vasodilator Reserve. American Journal of Cardiology, 56, 242-246. https://doi.org/10.1016/0002-9149(85)90842-2
|
[25]
|
Thadani, U. (2004) Current Medical Management of Chronic Stable Angina. Journal of Cardiovascular Pharmacology and Therapeutics, 9, S11-S29. https://doi.org/10.1177/107424840400900103
|
[26]
|
Timmis, A.D., Chaitman, B.R. and Crager, M. (2006) Effects of Ranolazine on Exercise Tolerance and HbA1c in Patients with Chronic Angina and Diabetes. European Heart Journal, 27, 42-48. https://doi.org/10.1093/eurheartj/ehi495
|
[27]
|
Chaitman, B.R., et al. (2004) Effects of Ranolazine with Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients with Severe Chronic Angina: A Randomized Controlled Trial. JAMA, 291, 309-316.
https://doi.org/10.1001/jama.291.3.309
|
[28]
|
Belardinelli, L., Shryock, J.C. and Fraser, H. (2006) Inhibition of the Late Sodium Current ASA Potential Cardioprotective Principle: Effects of the Late Sodium Current Inhibitor Ranolazine. Heart, 92, iv6-iv14.
https://doi.org/10.1136/hrt.2005.078790
|
[29]
|
Samin, A., Nugent, L., Mehta, P.K., Shufelt, C. and BaireyMerz, C.N. (2010) Treatment of Angina and Coronary Microvascular Dysfunction. Current Treatment Options in Cardiovascular Medicine, 12, 355-364.
https://doi.org/10.1007/s11936-010-0083-8
|
[30]
|
Hemingway, H., et al. (2006) Incidence and Prognostic Implications of Stable Angina Pectoris among Women and Men. JAMA, 295, 1404-1411. https://doi.org/10.1001/jama.295.12.1404
|
[31]
|
Holubkoy, R., et al. (2002) Angina 1 Year after Percutaneous Coronary Intervention: A Report from the NHLBI Dynamic Registry. American Heart Journal, 144, 826-833. https://doi.org/10.1067/mhj.2002.125505
|
[32]
|
Johnson, B.D., et al. (2004) Prognosis in Women with Myocardial Ischemia in the Absence of Obstructive Coronary Artery Disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation, 109, 2993-2999.
https://doi.org/10.1016/j.accreview.2004.08.007
|
[33]
|
Pepine, C.J. (2004) Ischemic Heart Disease in Women: Facts and Wishful Thinking. Journal of the American College of Cardiology, 43, 1727-1730. https://doi.org/10.1016/j.jacc.2004.04.012
|
[34]
|
Pepine, C.J. (2006) Ischemic Heart Disease in Women. Journal of the American College of Cardiology, 47, S1-S3.
https://doi.org/10.1016/j.jacc.2005.10.022
|
[35]
|
Mehta, P.K., et al. (2011) Ranolazine Improves Angina in Women with Evidence of Myocardial Ischemia But No Obstructive Coronary Artery Disease. JACC: Cardiovascular Imaging, 4, 514-522.
https://doi.org/10.1016/j.jcmg.2011.03.007
|
[36]
|
Wenger, N.K., Chaitman, B. and Vetrovec, G.W. (2007) Gender Comparison of Efficacy and Safety of Ranolazine for Chronic Angina Pectoris in Four Randomized Clinical Trials. American Journal of Cardiology, 99, 11-18.
https://doi.org/10.1016/j.amjcard.2006.07.052
|
[37]
|
Skalidis, E.I., Hamilos, M.I., Chlouverakis, G., Zacharis, E.A. and Vardas, P.E. (2011) Ivabradine Improves Coronary Flow Reserve in Patients with Stable Coronary Artery Disease. Atherosclerosis, 215, 160-165.
https://doi.org/10.1016/j.atherosclerosis.2010.11.035
|
[38]
|
Villano, A., et al. (2013) Effects of Ivabradine and Ranolazine in Patients with Microvascular Angina Pectoris. American Journal of Cardiology, 112, 8-13. https://doi.org/10.1016/j.amjcard.2013.02.045
|
[39]
|
Emdin, M., Picano, E., Lattanzi, F. and L’Abbate, A. (1989) Improved Exercise Capacity with Acute Aminophylline Administration in Patients with Syndrome X. JACC: Journal of the American College of Cardiology, 14, 1450-1453.
https://doi.org/10.1016/0735-1097(89)90380-X
|
[40]
|
Chen, J.W., Hsu, N.W., Wu, T.C., Lin, S.J. and Chang, M.S. (2002) Long-Term Angiotensin-Converting Enzyme Inhibition Reduces Plasma Asymmetric Dimethylarginine and Improves Endothelial Nitric Oxide Bioavailability and Coronary Microvascular Function in Patients with Syndrome X. American Journal of Cardiology, 90, 974-982.
https://doi.org/10.1016/S0002-9149(02)02664-4
|
[41]
|
Bøtker, H.E., Sonne, H.S., Schmitz, O. and Nielsen, T.T. (1989) Effects of Doxazosin on Exercise-Induced Angina Pectoris, ST-Segment Depression, and Insulin Sensitivity in Patients with Syndrome X. American Journal of Cardiology, 82, 1352-1356. https://doi.org/10.1016/S0002-9149(98)00640-7
|
[42]
|
Vicari, R.M., et al. (2005) Efficacy and Safety of Fasudil in Patients with Stable Angina: A Double-Blind, Placebo-Controlled, Phase 2 Trial. Journal of the American College of Cardiology, 46, 1803-1811.
|
[43]
|
Denardo, S.J., et al. (2011) Effect of Phosphodiesterase Type 5 Inhibition on Microvascular Coronary Dysfunction in Women: A Women’s Ischemia Syndrome Evaluation (WISE) Ancillary Study. Clinical Cardiology, 34, 483-487.
https://doi.org/10.1002/clc.20935
|
[44]
|
Yang, J., Cong, X.L. and Wu, Z.G. (2015) Study on Danhong Injection in Treatment of Coronary Microvascular Dysfunction. Journal of Hubei University of Chinese Medicine, 17, 34-36.
|
[45]
|
李善春, 杨军, 方毅民, 等. 川芎嗪对急性心肌梗死急诊冠状动脉介入治疗后“心肌无复流”的影响[J]. 中华核医学杂志, 2006, 26(6): 366-369.
|
[46]
|
杨秀秀, 陈韵岱, 田峰, 等. 葛根素对兔急性心肌梗死再灌注后无复流的影响[J]. 中国循环杂志, 2010, 25(1): 30-33.
|
[47]
|
何传飞, 王祥, 余浩, 等. 姜黄素对大鼠急性心肌缺血再灌注后无复流的影响及机制研究[J]. 中华心血管病杂志, 2009, 37(增刊): 377.
|
[48]
|
朱海燕. 黄芪多糖对人心脏微血管内皮细胞再灌注损伤粘附分子表达及调控的研究[D]: [博士学位论文]. 北京: 北京中医药大学, 2008 .
|
[49]
|
Kronhaus, K.D. and Lawson, W.E. (2009) Enhanced External Counterpulsation Is an Effective Treatment for Syndrome X. International Journal of Cardiology, 135, 256-257. https://doi.org/10.1016/j.ijcard.2008.03.022
|
[50]
|
Di Pede, F., et al. (2003) Immediate and Long-Term Clinical Outcome after Spinal Cord Stimulation for Refractory Stable Angina Pectoris. American Journal of Cardiology, 91, 951-955.
https://doi.org/10.1016/S0002-9149(03)00110-3
|
[51]
|
van Peski-Oosterbaan, A.S., et al. (1999) Cognitive-Behavioral Therapy for Noncardiac Chest Pain: A Randomized Trial. The American Journal of Medicine, 106, 424-429. https://doi.org/10.1016/S0002-9343(99)00049-2
|
[52]
|
Chauhan, A., et al. (1994) Effect of Transcutaneous Electrical Nerve Stimulation on Coronary Blood Flow. Circulation, 89, 694-702. https://doi.org/10.1161/01.CIR.89.2.694
|
[53]
|
Lanza, G.A., et al. (2005) Effect of Spinal Cord Stimulation on Spontaneous and Stress-Induced Angina and “Ischemic-Like” ST-Segment Depression in Patients with Cardiac Syndrome X. European Heart Journal, 26, 983-989.
https://doi.org/10.1093/eurheartj/ehi089
|
[54]
|
Anderson, J.L., et al. (2007) ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction): Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation, 116, 148-304.
https://doi.org/10.1161/CIRCULATIONAHA.107.185752
|
[55]
|
Asbury, E.A., Kanji, N., Ernst, E., Barbir, M. and Collins, P. (2009) Autogenic Training to Manage Symptomology in Women with Chest Pain and Normal Coronary Arteries. Menopause, 16, 60-65.
https://doi.org/10.1097/gme.0b013e318184762e
|